We are excited to share that the 2025 application cycle for the BioTools Innovator and MedTech Innovator programmes is now open! Are you an EIC beneficiary actively developing life science tools and enabling technologies, medical devices, diagnostics or digital health products to improve human health?
Apply by 15 January to join the 2025 cohorts and get the chance to win up to USD 800 000 in non-dilutive prizes!
Apply for the BioTools Innovator programme by 15 January.
About MedTech Innovator and BioTools Innovator
MedTech Innovator is one of the world’s largest accelerators for medical device, digital health and patient diagnostics companies. Its mission is to support start-ups revolutionising patient care and improving healthcare outcomes.
MedTech Innovator connects entrepreneurs with top-tier mentors, investors and strategic partners, providing invaluable resources and guidance to help companies overcome obstacles and seize new opportunities.
BioTools Innovator, powered by MedTech Innovator, focuses on advancing life science tools and enabling technologies. It nurtures start-ups addressing challenges and creating new opportunities in drug discovery and diagnostics. BioTools Innovator shares MedTech Innovator’s commitment to accelerating the growth of entrepreneurs whose innovations are transforming the healthcare landscape.
Are you eager to meet them and plan to attend the J.P. Morgan Week in San Francisco on 13-16 January 2025? BioTools Innovator will be on the ground getting to know EIC beneficiaries!
With nearly 12 000 applicants reviewed, 717 companies supported and over USD 8.7 billion in funding raised, MedTech Innovator and BioTools Innovator are at the forefront of driving health innovation.
How does this help you and what can you expect?
Both programmes offer unparalleled access to top-tier mentoring, coaching and education in a tailored 4-month curriculum designed to help innovators overcome obstacles and bring their products to market quickly and effectively.
A robust schedule of in-person events and virtual webinars delivers timely, relevant insights from industry experts who have ‘been there and done that’.
Finalists are also eligible for up to USD 800 000 in non-dilutive cash prizes, helping fuel ongoing innovation.
Please note: MedTech Innovator and BioTools Innovator do not charge or take equity for participation, and there is no application fee.
Eligibility and requirements
All early- to mid-stage medical device, diagnostics or digital health EIC-funded companies are encouraged to apply.
Have any doubts or queries? Visit the official MedTech Innovator and BioTools Innovator websites.
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.